{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T22:50:10Z","timestamp":1792450210485,"version":"4.5.0"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.canlet.2025.217783","type":"journal-article","created":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T02:57:42Z","timestamp":1746586662000},"page":"217783","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Mechanistic insights into CLNS1A-mediated chemoresistance and tumor progression in non-small cell lung cancer"],"prefix":"10.1016","volume":"626","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4578-5668","authenticated-orcid":false,"given":"Tong-You Wade","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiun-Yi","family":"Hsia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsung-Ying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4402-1729","authenticated-orcid":false,"given":"Yu-Xu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9294-6183","authenticated-orcid":false,"given":"Guo-Zhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1437-0363","authenticated-orcid":false,"given":"Yi-Chung","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Wun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangzhou","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo-Mei Maureen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Jun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping-Chiang","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Jen","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Chih","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4468-6329","authenticated-orcid":false,"given":"Chang-Tze Ricky","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2025.217783_bib1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/bbrc.1995.1309","article-title":"Molecular cloning of the human volume-sensitive chloride conductance regulatory protein, pICln, from ocular ciliary epithelium","volume":"208","author":"Anguita","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"Pt 2","key":"10.1016\/j.canlet.2025.217783_bib2","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1042\/bj3270609","article-title":"Molecular cloning and expression of a chloride channel-associated protein pICln in human young red blood cells: association with actin","volume":"327","author":"Schwartz","year":"1997","journal-title":"Biochem. J."},{"key":"10.1016\/j.canlet.2025.217783_bib3","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s004240000250","article-title":"Functional reconstitution of ICln in lipid bilayers","volume":"440","author":"F\u00fcrst","year":"2000","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.canlet.2025.217783_bib4","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1016\/S0091-6749(96)70023-4","article-title":"ICln: a chloride channel paramount for cell volume regulation","volume":"98","author":"Gschwentner","year":"1996","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.canlet.2025.217783_bib5","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1006\/bbrc.1998.8571","article-title":"pICln can regulate swelling-induced Cl- currents in either layer of rabbit ciliary epithelium","volume":"246","author":"Chen","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2025.217783_bib6","first-page":"1023","article-title":"ICln, an ion channel-forming protein associated with cell volume regulation","volume":"84","author":"Gschwentner","year":"1999","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.canlet.2025.217783_bib7","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/37151","article-title":"Molecular identification of a volume-regulated chloride channel","volume":"390","author":"Duan","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2025.217783_bib8","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/ki.1997.65","article-title":"ICln, a chloride channel cloned from kidney cells, is activated during regulatory volume decrease","volume":"51","author":"Laich","year":"1997","journal-title":"Kidney Int."},{"key":"10.1016\/j.canlet.2025.217783_bib9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.molmed.2010.01.005","article-title":"Ion channels and the hallmarks of cancer","volume":"16","author":"Prevarskaya","year":"2010","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.canlet.2025.217783_bib10","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1152\/physrev.00044.2016","article-title":"Ion channels in cancer: are cancer hallmarks oncochannelopathies?","volume":"98","author":"Prevarskaya","year":"2018","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.canlet.2025.217783_bib11","article-title":"Chloride channels and transporters: roles beyond classical cellular homeostatic pH or ion balance in cancers","volume":"14","author":"Kim","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canlet.2025.217783_bib12","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2013.0104","article-title":"Ion channels and apoptosis in cancer","volume":"369","author":"Bortner","year":"2014","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.canlet.2025.217783_bib13","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.bbamcr.2015.11.032","article-title":"Pharmacological targeting of ion channels for cancer therapy: in vivo evidences","volume":"1863","author":"Leanza","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.canlet.2025.217783_bib14","article-title":"The modulation of ion channels in cancer chemo-resistance","volume":"12","author":"Zhao","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2025.217783_bib15","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1038\/s41417-024-00782-8","article-title":"Pathophysiological role of ion channels and transporters in hepatocellular carcinoma","volume":"31","author":"Zhang","year":"2024","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.canlet.2025.217783_bib16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0092-8674(92)90263-C","article-title":"Separation of drug transport and chloride channel functions of the human multidrug resistance P-glycoprotein","volume":"71","author":"Gill","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2025.217783_bib17","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF00233309","article-title":"Drug-transport and volume-activated chloride channel functions in human erythroleukemia cells: relation to expression level of P-glycoprotein","volume":"145","author":"Viana","year":"1995","journal-title":"J. Membr. Biol."},{"key":"10.1016\/j.canlet.2025.217783_bib18","article-title":"The role of chloride channels in the multidrug resistance","volume":"12","author":"Wilczynski","year":"2021","journal-title":"Membranes (Basel)"},{"key":"10.1016\/j.canlet.2025.217783_bib19","doi-asserted-by":"crossref","first-page":"C541","DOI":"10.1152\/ajpcell.00102.2011","article-title":"Ion channels and transporters [corrected] in cancer. 2. Ion channels and the control of cancer cell migration","volume":"301","author":"Cuddapah","year":"2011","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.canlet.2025.217783_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0299-y","article-title":"The inhibition of chloride intracellular channel 1 enhances Ca(2+) and reactive oxygen species signaling in A549 human lung cancer cells","volume":"51","author":"Lee","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.canlet.2025.217783_bib21","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrd2780","article-title":"Chloride channels as drug targets","volume":"8","author":"Verkman","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.canlet.2025.217783_bib22","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.bbrc.2008.06.070","article-title":"Pharmacologic blockade of chloride channel synergistically enhances apoptosis of chemotherapeutic drug-resistant cancer stem cells","volume":"373","author":"Kang","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2025.217783_bib23","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2013.0109","article-title":"Ion channels and transporters in the development of drug resistance in cancer cells","volume":"369","author":"Hoffmann","year":"2014","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.canlet.2025.217783_bib24","doi-asserted-by":"crossref","first-page":"9674","DOI":"10.1074\/jbc.M115.636894","article-title":"Histone H2A and H4 N-terminal tails are positioned by the MEP50 WD repeat protein for efficient methylation by the PRMT5 arginine methyltransferase","volume":"290","author":"Burgos","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2025.217783_bib25","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1016\/j.cellsig.2014.09.014","article-title":"Methylosome protein 50 promotes androgen- and estrogen-independent tumorigenesis","volume":"26","author":"Wei","year":"2014","journal-title":"Cell. Signal."},{"key":"10.1016\/j.canlet.2025.217783_bib26","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1016\/S0960-9822(01)00592-9","article-title":"Methylation of Sm proteins by a complex containing PRMT5 and the putative U snRNP assembly factor pICln","volume":"11","author":"Meister","year":"2001","journal-title":"Curr. Biol."},{"key":"10.1016\/j.canlet.2025.217783_bib27","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1016\/j.molcel.2021.07.019","article-title":"Molecular basis for substrate recruitment to the PRMT5 methylosome","volume":"81","author":"Mulvaney","year":"2021","journal-title":"Mol Cell"},{"key":"10.1016\/j.canlet.2025.217783_bib28","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1074\/jbc.M110.148486","article-title":"RioK1, a new interactor of protein arginine methyltransferase 5 (PRMT5), competes with pICln for binding and modulates PRMT5 complex composition and substrate specificity","volume":"286","author":"Guderian","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2025.217783_bib29","doi-asserted-by":"crossref","first-page":"21347","DOI":"10.1074\/jbc.M109.015578","article-title":"Role of pICLn in methylation of Sm proteins by PRMT5","volume":"284","author":"Pesiridis","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2025.217783_bib30","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/s12276-021-00613-y","article-title":"Protein arginine methyltransferases: promising targets for cancer therapy","volume":"53","author":"Hwang","year":"2021","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.canlet.2025.217783_bib31","doi-asserted-by":"crossref","first-page":"199","DOI":"10.15698\/cst2020.08.228","article-title":"PRMT5 function and targeting in cancer","volume":"4","author":"Kim","year":"2020","journal-title":"Cell Stress"},{"key":"10.1016\/j.canlet.2025.217783_bib32","doi-asserted-by":"crossref","first-page":"8407","DOI":"10.1021\/acs.jmedchem.3c00250","article-title":"Targeting arginine methyltransferase PRMT5 for cancer therapy: updated progress and novel strategies","volume":"66","author":"Zheng","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.canlet.2025.217783_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112252","article-title":"Targeting protein arginine methyltransferase 5 in cancers: roles, inhibitors and mechanisms","volume":"144","author":"Chen","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.canlet.2025.217783_bib34","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1038\/s41467-021-23833-2","article-title":"PRMT5-mediated arginine methylation activates AKT kinase to govern tumorigenesis","volume":"12","author":"Yin","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2025.217783_bib35","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1111\/j.1349-7006.2012.02367.x","article-title":"Protein arginine methyltransferase 5 is a potential oncoprotein that upregulates G1 cyclins\/cyclin-dependent kinases and the phosphoinositide 3-kinase\/AKT signaling cascade","volume":"103","author":"Wei","year":"2012","journal-title":"Cancer Sci."},{"key":"10.1016\/j.canlet.2025.217783_bib36","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1158\/1535-7163.MCT-22-0746","article-title":"The role of protein arginine methyltransferases in pathogenesis and treatment of digestive system carcinoma","volume":"22","author":"Wang","year":"2023","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.canlet.2025.217783_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.725301","article-title":"Protein arginine methyltransferase 5 functions via interacting proteins","volume":"9","author":"Liang","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.canlet.2025.217783_bib38","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1186\/s12885-016-2632-3","article-title":"Protein arginine methyltransferase 5 regulates multiple signaling pathways to promote lung cancer cell proliferation","volume":"16","author":"Sheng","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canlet.2025.217783_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.879057","article-title":"Inhibition of the protein arginine methyltransferase PRMT5 in high-risk multiple myeloma as a novel treatment approach","volume":"10","author":"Vlummens","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.canlet.2025.217783_bib40","doi-asserted-by":"crossref","first-page":"4904","DOI":"10.1158\/0008-5472.CAN-20-1228","article-title":"Protein arginine methyltransferase 5 promotes pICln-dependent androgen receptor transcription in castration-resistant prostate cancer","volume":"80","author":"Beketova","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2025.217783_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.891652","article-title":"Multidrug resistance in cancer: understanding molecular mechanisms, immunoprevention and therapeutic approaches","volume":"12","author":"Emran","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2025.217783_bib42","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41392-019-0099-9","article-title":"The emerging treatment landscape of targeted therapy in non-small-cell lung cancer","volume":"4","author":"Yuan","year":"2019","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.canlet.2025.217783_bib43","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12935-023-02990-y","article-title":"Recent advances in non-small cell lung cancer targeted therapy; an update review","volume":"23","author":"Araghi","year":"2023","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.canlet.2025.217783_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.265","article-title":"Understanding and targeting resistance mechanisms in cancer","volume":"4","author":"Lei","year":"2023","journal-title":"MedComm"},{"key":"10.1016\/j.canlet.2025.217783_bib45","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1093\/bioinformatics\/btu364","article-title":"CAVER Analyst 1.0: graphic tool for interactive visualization and analysis of tunnels and channels in protein structures","volume":"30","author":"Kozlikova","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.canlet.2025.217783_bib46","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1093\/bioinformatics\/bty386","article-title":"CAVER Analyst 2.0: analysis and visualization of channels and tunnels in protein structures and molecular dynamics trajectories","volume":"34","author":"Jurcik","year":"2018","journal-title":"Bioinformatics"},{"key":"10.1016\/j.canlet.2025.217783_bib47","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2005365","article-title":"The WNK-SPAK\/OSR1 pathway: master regulator of cation-chloride cotransporters","volume":"7","author":"Alessi","year":"2014","journal-title":"Sci. Signal."},{"key":"10.1016\/j.canlet.2025.217783_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.585907","article-title":"Physiological processes modulated by the chloride-sensitive WNK-SPAK\/OSR1 kinase signaling pathway and the cation-coupled chloride cotransporters","volume":"11","author":"Murillo-de-Ozores","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.canlet.2025.217783_bib49","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.cmet.2017.01.007","article-title":"WNK kinase signaling in ion homeostasis and human disease","volume":"25","author":"Shekarabi","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.canlet.2025.217783_bib50","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF00048965","article-title":"Cell detachment and metastasis","volume":"2","author":"Weiss","year":"1983","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.canlet.2025.217783_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12092137","article-title":"Circulating tumor cells: origin, role, current applications, and future perspectives for personalized medicine","volume":"12","author":"Rapanotti","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.canlet.2025.217783_bib52","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/112_2021_62","article-title":"Potassium and chloride ion channels in cancer: a novel paradigm for cancer therapeutics","volume":"183","author":"Banderali","year":"2022","journal-title":"Rev. Physiol. Biochem. Pharmacol."},{"key":"10.1016\/j.canlet.2025.217783_bib53","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1016\/S0960-9822(01)00583-8","article-title":"Coordination of cell polarization and migration by the Rho family GTPases requires Src tyrosine kinase activity","volume":"11","author":"Timpson","year":"2001","journal-title":"Curr. Biol."},{"key":"10.1016\/j.canlet.2025.217783_bib54","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s40164-023-00446-7","article-title":"Focal adhesion kinase: from biological functions to therapeutic strategies","volume":"12","author":"Tan","year":"2023","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.canlet.2025.217783_bib55","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ceb.2006.08.011","article-title":"Integrin-regulated FAK-Src signaling in normal and cancer cells","volume":"18","author":"Mitra","year":"2006","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.canlet.2025.217783_bib56","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/s41416-020-0970-z","article-title":"IQGAP1 promotes anoikis resistance and metastasis through Rac1-dependent ROS accumulation and activation of Src\/FAK signalling in hepatocellular carcinoma","volume":"123","author":"Mo","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2025.217783_bib57","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00000421-199702000-00007","article-title":"Combined carboplatin and cisplatin therapy in patients with advanced non-small cell lung cancer","volume":"20","author":"Nakanishi","year":"1997","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2025.217783_bib58","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1200\/JCO.1987.5.8.1281","article-title":"Platinum analogue combination chemotherapy: cisplatin and carboplatin--a phase I trial with pharmacokinetic assessment of the effect of cisplatin administration on carboplatin excretion","volume":"5","author":"Trump","year":"1987","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2025.217783_bib59","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/00008390-200108000-00012","article-title":"Cisplatin and carboplatin combination as second-line chemotherapy in dacarbazine-resistant melanoma patients","volume":"11","author":"Guven","year":"2001","journal-title":"Melanoma Res."},{"key":"10.1016\/j.canlet.2025.217783_bib60","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1124\/mol.109.055178","article-title":"Cisplatin-induced DNA damage activates replication checkpoint signaling components that differentially affect tumor cell survival","volume":"76","author":"Wagner","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.canlet.2025.217783_bib61","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1186\/1471-2407-9-359","article-title":"DNA damage induced by cis- and carboplatin as indicator for in vitro sensitivity of ovarian carcinoma cells","volume":"9","author":"Unger","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canlet.2025.217783_bib62","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1158\/2767-9764.CRC-23-0070","article-title":"PRMT5 inhibitors regulate DNA damage repair pathways in cancer cells and improve response to PARP inhibition and chemotherapies","volume":"3","author":"Carter","year":"2023","journal-title":"Cancer Res. Commun."},{"key":"10.1016\/j.canlet.2025.217783_bib63","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23179780","article-title":"The role of protein arginine methyltransferases in DNA damage response","volume":"23","author":"Brobbey","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2025.217783_bib64","doi-asserted-by":"crossref","first-page":"8289","DOI":"10.1128\/MCB.21.24.8289-8300.2001","article-title":"The methylosome, a 20S complex containing JBP1 and pICln, produces dimethylarginine-modified Sm proteins","volume":"21","author":"Friesen","year":"2001","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2025.217783_bib65","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S1097-2765(01)00244-1","article-title":"SMN, the product of the spinal muscular atrophy gene, binds preferentially to dimethylarginine-containing protein targets","volume":"7","author":"Friesen","year":"2001","journal-title":"Mol Cell"},{"key":"10.1016\/j.canlet.2025.217783_bib66","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.molcel.2017.01.019","article-title":"PRMT5-Dependent methylation of the TIP60 coactivator RUVBL1 is a key regulator of homologous recombination","volume":"65","author":"Clarke","year":"2017","journal-title":"Mol Cell"},{"key":"10.1016\/j.canlet.2025.217783_bib67","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41419-024-06651-4","article-title":"RUVBL1 ubiquitination by DTL promotes RUVBL1\/2-beta-catenin-mediated transcriptional regulation of NHEJ pathway and enhances radiation resistance in breast cancer","volume":"15","author":"Tian","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2025.217783_bib68","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.dnarep.2016.02.004","article-title":"DNA damage response (DDR) pathway engagement in cisplatin radiosensitization of non-small cell lung cancer","volume":"40","author":"Sears","year":"2016","journal-title":"DNA Repair (Amst)"},{"key":"10.1016\/j.canlet.2025.217783_bib69","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/s41420-021-00511-2","article-title":"Smac-mimetic enhances antitumor effect of standard chemotherapy in ovarian cancer models via Caspase 8-independent mechanism","volume":"7","author":"Hernandez","year":"2021","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.canlet.2025.217783_bib70","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.abm6211","article-title":"The PIKK-AKT connection in the DNA damage response","volume":"15","author":"Shin","year":"2022","journal-title":"Sci. Signal."},{"key":"10.1016\/j.canlet.2025.217783_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.102021","article-title":"Targeting the PI3K pathway and DNA damage response as a therapeutic strategy in ovarian cancer","volume":"86","author":"Huang","year":"2020","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.canlet.2025.217783_bib72","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201745235","article-title":"Phosphorylation switches Bax from promoting to inhibiting apoptosis thereby increasing drug resistance","volume":"19","author":"Kale","year":"2018","journal-title":"EMBO Rep"},{"key":"10.1016\/j.canlet.2025.217783_bib73","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/cdd.2017.170","article-title":"Anti-apoptotic BCL-2 family members in development","volume":"25","author":"Opferman","year":"2018","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.canlet.2025.217783_bib74","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/s41419-020-2589-7","article-title":"BCL-xL\/BCL2L1 is a critical anti-apoptotic protein that promotes the survival of differentiating pancreatic cells from human pluripotent stem cells","volume":"11","author":"Loo","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2025.217783_bib75","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/s41419-020-02998-6","article-title":"PI3K\/AKT pathway as a key link modulates the multidrug resistance of cancers","volume":"11","author":"Liu","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2025.217783_bib76","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.18632\/oncotarget.809","article-title":"Coordinate PI3K pathway and Bcl-2 family disruption in AML","volume":"3","author":"Bose","year":"2012","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2025.217783_bib77","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/sj.cdd.4400783","article-title":"Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c","volume":"7","author":"Korsmeyer","year":"2000","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.canlet.2025.217783_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2022.119317","article-title":"Pro-apoptotic complexes of BAX and BAK on the outer mitochondrial membrane","volume":"1869","author":"Wolf","year":"2022","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.canlet.2025.217783_bib79","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s42003-018-0275-4","article-title":"MEP50\/PRMT5-mediated methylation activates GLI1 in Hedgehog signalling through inhibition of ubiquitination by the ITCH\/NUMB complex","volume":"2","author":"Abe","year":"2019","journal-title":"Commun. Biol."},{"key":"10.1016\/j.canlet.2025.217783_bib80","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1038\/s41467-019-10652-9","article-title":"Targeting enhancer switching overcomes non-genetic drug resistance in acute myeloid leukaemia","volume":"10","author":"Bell","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2025.217783_bib81","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3389\/fonc.2014.00040","article-title":"In vitro development of chemotherapy and targeted therapy drug-resistant cancer cell lines: a practical guide with case studies","volume":"4","author":"McDermott","year":"2014","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2025.217783_bib82","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/s41571-022-00672-8","article-title":"Is early-onset cancer an emerging global epidemic? Current evidence and future implications","volume":"19","author":"Ugai","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2025.217783_bib83","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41392-023-01341-7","article-title":"Targeting epigenetic regulators to overcome drug resistance in cancers","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct. Target. Ther."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525003490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525003490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T23:01:44Z","timestamp":1760742104000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383525003490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":83,"alternative-id":["S0304383525003490"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2025.217783","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanistic insights into CLNS1A-mediated chemoresistance and tumor progression in non-small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2025.217783","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"217783"}}